Your browser doesn't support javascript.
loading
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Holmberg-Thydén, Staffan; Dufva, Inge Høgh; Gang, Anne Ortved; Breinholt, Marie Fredslund; Schejbel, Lone; Andersen, Mette Klarskov; Kadivar, Mohammad; Svane, Inge Marie; Grønbæk, Kirsten; Hadrup, Sine Reker; El Fassi, Daniel.
Affiliation
  • Holmberg-Thydén S; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Dufva IH; Experimental & Translational Immunology (XTI), Health Technology, T-Cells and Cancer, Technical University of Denmark, Lyngby, Denmark.
  • Gang AO; Department of Oncology and Palliative Care, Copenhagen University Hospital, Hillerød, Denmark.
  • Breinholt MF; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Schejbel L; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Andersen MK; Department of Pathology, Copenhagen University Hospital, Herlev, Denmark.
  • Kadivar M; Department of Pathology, Copenhagen University Hospital, Herlev, Denmark.
  • Svane IM; Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Grønbæk K; Experimental & Translational Immunology (XTI), Health Technology, T-Cells and Cancer, Technical University of Denmark, Lyngby, Denmark.
  • Hadrup SR; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • El Fassi D; National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.
Cancer Immunol Immunother ; 71(2): 433-444, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34218294
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Cancer Vaccines / Epigenesis, Genetic / Antigens, Neoplasm Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Cancer Vaccines / Epigenesis, Genetic / Antigens, Neoplasm Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: Germany